Vident Advisory’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10M Buy
117,746
+1,574
+1% +$140K 0.09% 203
2025
Q4
$9.18M Sell
116,172
-3,047
-3% -$239K 0.08% 206
2025
Q3
$9.53M Buy
119,219
+90,203
+311% +$7.69M 0.09% 199
2025
Q2
$2.64M Buy
29,016
+3,519
+14% +$321K 0.03% 431
2025
Q1
$2.39M Sell
25,497
-12,497
-33% -$1.12M 0.03% 418
2024
Q4
$3.45M Buy
37,994
+17,919
+89% +$1.71M 0.06% 288
2024
Q3
$2.08M Buy
20,075
+9,329
+87% +$951K 0.05% 376
2024
Q2
$1.04M Buy
10,746
+2,176
+25% +$201K 0.03% 581
2024
Q1
$772K Buy
8,570
+712
+9% +$60.3K 0.02% 666
2023
Q4
$626K Buy
7,858
+1,759
+29% +$132K 0.02% 697
2023
Q3
$434K Buy
+6,099
New +$456K 0.01% 751

Other funds holding CL

Vident Advisory's CL Position: Q1 2026 in Review

Vident Advisory increased its Colgate-Palmolive (CL) stake by 1.4% in Q1 2026, buying an estimated $140K and bringing the position to 117,746 shares worth $10M. The position accounts for 0.09% of the portfolio, ranked #203.

Vident Advisory first reported a position in CL in Q3 2023 and has held it in 11 quarters since. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Vident Advisory held 117,746 shares of Colgate-Palmolive worth $10M as of Q1 2026.
  • Vident Advisory bought 1,574 Colgate-Palmolive shares in Q1 2026, an estimated $140K.
  • Colgate-Palmolive made up 0.09% of Vident Advisory's portfolio in Q1 2026, its #203 holding.
  • Vident Advisory first reported a position in Colgate-Palmolive in Q3 2023 and has held it in 11 quarters since.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Vident Advisory's 13F filing for Q1 2026, filed 15 May 2026.